Education Lab/CME

Latanoprostene Bunod and its Nitric Oxide Moiety
CME

Latanoprostene Bunod and its Nitric Oxide Moiety

This activity is supported by educational grants from Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

Expiration Date: 5/21/2020
Credit Type(s): CME | Credit: 0.25

This educational activity will discuss modulation of aqueous humor outflow by nitric oxide and the efficacy of latanoprost bunod in treating open angle glaucoma….

go to activity»
When Anti-VEGF Agents Don’t Work: Using Intravitreal Steroids Alone or in Combination to Treat DME/DR— A Woman With Proliferative Diabetic Retinopathy Post Panretinal Photocoagulation With Mild Macular Edema

When Anti-VEGF Agents Don’t Work: Using Intravitreal Steroids Alone or in Combination to Treat DME/DR—A Woman With Longstanding Diabetes Presents With Decreased…

go to activity»
Improving the Burden of Treatment for Age-related Macular Degeneration through Advances in Delivery
CME

Improving the Burden of Treatment for Age-related Macular Degeneration Through Advances in Delivery

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 5/2/2020
Credit Type(s): CME | Credit: 0.75

Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy has revolutionized the treatment of age-related macular degeneration (AMD), but it has…

go to activity»
J768
CME

Preserving the Ocular Surface: Practice Pearls—Part IV

This activity is supported by educational grants from Alcon Laboratories, Inc.; Allergan, Inc.; Bausch + Lomb; Kala Pharmaceuticals; and Shire.

Expiration Date: 4/3/2020
Credit Type(s): CME | Credit: 0.75

Ocular surface disease (OSD) is a group of disorders commonly encountered in ophthalmic practice, but is challenging to diagnose and is often undertreated. However…

go to activity»
J773_HEA002
CME

MIGS and Cataract Surgery

This activity is supported by educational grants from Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

Expiration Date: 4/2/2020
Credit Type(s): CME | Credit: 0.25

This educational video will discuss the benefits and complications of minimally invasive glaucoma surgery….

go to activity»
Rapid Response From Retina World Congress – Transitioning Treatment in Diabetic Retinopathy
CME

Rapid Response From Retina World Congress – Transitioning Treatment in Diabetic Retinopathy

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/30/2020
Credit Type(s): CME | Credit: 0.75

Intravitreal therapy has rapidly evolved to become a mainstay of treatment for many retinal diseases, offering delayed or arrested disease progression and the…

go to activity»
M439_HEA003
CME

When Anti-VEGF Agents Don’t Work: Using Intravitreal Steroids Alone or in Combination to Treat DME/DR—Vision Is More Than Just Best Corrected Visual Acuity in Diabetic Macular Edema

This activity is supported by an educational grant from Allergan, Inc.

Expiration Date: 4/30/2020
Credit Type(s): CME | Credit: 0.25

Retina specialists and ophthalmologists play a critical role in the management of DME and DR, conditions that are among the most common causes of blindness among…

go to activity»
When Anti-VEGF Agents Don’t Work: Using Intravitreal Steroids Alone or in Combination to Treat DME/DR—A Woman With Longstanding Diabetes Presents With Decreased Vision
CME

When Anti-VEGF Agents Don’t Work: Using Intravitreal Steroids Alone or in Combination to Treat DME/DR—A Woman With Longstanding Diabetes Presents With Decreased Vision

This activity is provided by Global Education Group.

Expiration Date: 4/30/2020
Credit Type(s): CME | Credit: 0.25

Explore the treatment options for a patient with longstanding diabetes and decreased vision presented by Dr Arshad Khanani with faculty discussion of the choices…

go to activity»
J582
CME

Diabetic Retinopathy: Assessing the Armamentarium for Improved Detection and Treatment

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 4/11/2020
Credit Type(s): CME | Credit: 0.75

Anti-VEGF therapy is an important addition to the treatment options for diabetic retinopathy (DR) and is the only medical option that has been granted US Food and Drug…

go to activity»
Cataract Surgery Alone Lowers Intraocular Pressure
CME

Cataract Surgery Alone Lowers Intraocular Pressure

This activity is supported by educational grants from Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

Expiration Date: 4/2/2020
Credit Type(s): CME | Credit: 0.25

This educational activity will discuss the relationship between cataract surgery and IOP reduction….

go to activity»
Neuroprotection in Glaucoma
CME

Neuroprotection in Glaucoma

This activity is supported by educational grants from Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

Expiration Date: 4/2/2020
Credit Type(s): CME | Credit: 0.25

This educational activity will review the latest developments and concepts regarding neuroprotection in patients with glaucoma….

go to activity»
1,800 Seconds™ in Advances in the Management of Age-Related Macular Degeneration
CME

1,800 Seconds™ in Advances in the Management of Age-Related Macular Degeneration

Supported by an independent educational grant from Novartis Pharmaceuticals Corporation

Expiration Date: 3/31/2020
Credit Type(s): CME | Credit: 0.5

Age-related macular degeneration (AMD) is the leading cause of blind registration in industrialized countries, and the third leading cause of blindness internationally…

go to activity»